Market Overview

UPDATE: Stifel Nicolaus Raises PT to $117 on Stericycle Following Solid Q4

Related SRCL
Credit Suisse Believes Top Line Growth Matters More Than Margins For Stericycle
Benzinga's Top Upgrades

Stifel Nicolaus reiterated its Buy rating on Stericycle (NASDAQ: SRCL) and raised the price target from $102.00 to $117.00.

Stifel Nicolaus commented, "SRCL posted another solid quarter and raised guidance again. Revenue and EPS were ahead of estimates, though FCF came in within the expected range. We believe SRCL has largely completed the platform acquisitions it was making in the Patient Communications space that were weighing on company margins (they were declining), and margins have improved in each of the last two quarters."

Stericycle closed at $95.12 on Wednesday.

Posted-In: Stifel NicolausAnalyst Color Price Target Analyst Ratings

 

Most Popular

Related Articles (SRCL)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free